Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.

Lee CK, Zangari M, Barlogie B, Fassas A, van Rhee F, Thertulien R, Talamo G, Muwalla F, Anaissie E, Hollmig K, Tricot G.

Bone Marrow Transplant. 2004 Apr;33(8):823-8.

PMID:
14767499
2.

Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature.

Reiter E, Kalhs P, Keil F, Rabitsch W, Gisslinger H, Mayer G, Worel N, Lechner K, Greinix HT.

Ann Hematol. 1999 Apr;78(4):189-91. Review.

PMID:
10348151
3.

[Survival of myeloma patients treated with dialysis].

Martín Reyes G, Valera A, Frutos MA, Ramos B, Ordóñez V, López de Novales E.

Nefrologia. 2003;23(2):131-6. Review. Spanish.

4.

Multiple myeloma in end-stage renal disease.

Penfield JG.

Semin Dial. 2006 Jul-Aug;19(4):329-34. Review.

PMID:
16893412
5.

[Development and treatment of renal insufficiency in multiple myeloma].

Mølby L, Hansen HH, Jensen EL.

Ugeskr Laeger. 1994 Jul 25;156(30):4343-7. Review. Danish.

PMID:
8066935
6.

Renal failure in multiple myeloma: a medical emergency.

Wirk B.

Bone Marrow Transplant. 2011 Jun;46(6):771-83. doi: 10.1038/bmt.2011.8. Epub 2011 Feb 21. Review.

PMID:
21339749
7.

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.

Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA.

Am J Kidney Dis. 2005 Aug;46(2):270-7. Review.

PMID:
16112045
8.

High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction.

Pineda-Roman M, Tricot G.

Contrib Nephrol. 2007;153:182-94. Review.

PMID:
17075230
9.
10.

Renal impairment in myeloma: time for a reappraisal?

Mallick NP, Olujohungbe A, Drayson MT.

Nephrol Dial Transplant. 1998;13 Suppl 7:30-2. Review.

PMID:
9870434
11.

[Renal insufficiency in myelomatosis. Causes and treatment].

Knudsen LM, Hansen MT, Hippe E, Løkkegaard H.

Ugeskr Laeger. 1993 Nov 22;155(47):3823-7. Review. Danish.

PMID:
8256382
12.

Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Brown JH, Doherty CC.

Postgrad Med J. 1993 Sep;69(815):672-8. Review. No abstract available.

13.

Evolving treatments in multiple myeloma patients with renal failure.

Gozzetti A, Papini G, Candi V, Bocchia M.

Rev Recent Clin Trials. 2014;9(4):276-9. Review.

PMID:
25329484
14.

Is high cut-off hemodialysis effective in myeloma kidney?

Finkel KW.

Semin Dial. 2014 May-Jun;27(3):234-6. doi: 10.1111/sdi.12210. Epub 2014 Mar 25. Review. No abstract available.

PMID:
24666151
15.

Renal function in the elderly.

Rodger RS.

Br J Urol. 1998 Dec;82 Suppl 1:65-70. Review. No abstract available.

PMID:
9883264
16.

[Free light chains reduction on acute kidney injury in multiple myeloma: critical role of high cut-off membranes].

Buti E, Dervishi E, Ghiandai G, Mjeshtri A, Paudice N, Terreni A, Caldini A, Nozzoli C, Minetti EE, Bergesio F.

G Ital Nefrol. 2014 Nov-Dec;31(6). pii: gin/31.6.11. Review. Italian.

PMID:
25504169
17.

Multiple myeloma and renal failure.

Goldschmidt H, Lannert H, Bommer J, Ho AD.

Nephrol Dial Transplant. 2000 Mar;15(3):301-4. Review. No abstract available.

PMID:
10692511

Supplemental Content

Support Center